SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Yang Wu, Zhu Qin, Jinkai Ji, Ran Yang, Xiaoqiang Zhang, Yuanhui Li, Lihong Yin, Yuepu Pu, Xingsong Li, Galactosylated poly(ethylene glycol) methacrylate-st-3-guanidinopropyl methacrylamide copolymers as siRNA carriers for inhibiting Survivin expressionin vitroandin vivo, Journal of Drug Targeting, 2014, 22, 4, 352

    CrossRef

  2. 2
    Yiguan Xu, Shenghua Zhou, Zhenfei Fang, Xuping Li, Dekui Huang, Qiliang Liu, Chunhua Zheng, Inhibition of neointimal hyperplasia in rats treated with atorvastatin after carotid artery injury may be mainly associated with down-regulation of survivin and Fas expression, Pharmaceutical Biology, 2014, 52, 9, 1196

    CrossRef

  3. 3
    Mahsa Mobahat, Aru Narendran, Karl Riabowol, Survivin as a Preferential Target for Cancer Therapy, International Journal of Molecular Sciences, 2014, 15, 2, 2494

    CrossRef

  4. 4
    Sidi Yang, Yufei Chen, Roien Ahmadie, Emmanuel A. Ho, Advancements in the field of intravaginal siRNA delivery, Journal of Controlled Release, 2013, 167, 1, 29

    CrossRef

  5. 5
    Ana M. Cardoso, Sara Trabulo, Ana L. Cardoso, Sílvia Maia, Paula Gomes, Amália S. Jurado, Maria C. Pedroso de Lima, Comparison of the Efficiency of Complexes Based on S413-PV Cell-Penetrating Peptides in Plasmid DNA and siRNA Delivery, Molecular Pharmaceutics, 2013, 10, 7, 2653

    CrossRef

  6. 6
    Biology of Oral Cancer, 2013,

    CrossRef

  7. 7
    D J Morrison, L E Hogan, G Condos, T Bhatla, N Germino, N P Moskowitz, L Lee, D Bhojwani, T M Horton, I Belitskaya-Levy, L M Greenberger, I D Horak, S A Grupp, D T Teachey, E A Raetz, W L Carroll, Endogenous knockdown of survivin improves chemotherapeutic response in ALL models, Leukemia, 2012, 26, 2, 271

    CrossRef

  8. 8
    Hong-Ying Liao, Gui-Ping Wang, Li-Jia Gu, Shao-Hong Huang, Xiu-Ling Chen, Yun Li, Song-Wang Cai, HiF-1α siRNA and Cisplatin in Combination SuppressTumor Growth in a Nude Mice Model of Esophageal Squamous Cell Carcinoma, Asian Pacific Journal of Cancer Prevention, 2012, 13, 2, 473

    CrossRef

  9. 9
    Benjamin Sredni, Immunomodulating tellurium compounds as anti-cancer agents, Seminars in Cancer Biology, 2012, 22, 1, 60

    CrossRef

  10. You have open access to this content10
    Mei-Chuan Chen, Shiow-Lin Pan, Qian Shi, Zhiyan Xiao, Kuo-Hsiung Lee, Tsai-Kun Li, Che-Ming Teng, QS-ZYX-1-61 induces apoptosis through topoisomerase II in human non-small-cell lung cancer A549 cells, Cancer Science, 2012, 103, 1
  11. 11
    Wei-Qiong Yang, Yi Zhang, RNAi-mediated gene silencing in cancer therapy, Expert Opinion on Biological Therapy, 2012, 12, 11, 1495

    CrossRef

  12. 12
    Sanchareeka Dey, Tapas K. Maiti, Superparamagnetic Nanoparticles and RNAi-Mediated Gene Silencing: Evolving Class of Cancer Diagnostics and Therapeutics, Journal of Nanomaterials, 2012, 2012, 1

    CrossRef

  13. 13
    Astrid Weiss, Boris Brill, Corina Borghouts, Natalia Delis, Laura Mack, Bernd Groner, Survivin inhibition by an interacting recombinant peptide, derived from the human ferritin heavy chain, impedes tumor cell growth, Journal of Cancer Research and Clinical Oncology, 2012, 138, 7, 1205

    CrossRef

  14. You have open access to this content14
    Takahito Nakahara, Aya Kita, Kentaro Yamanaka, Masamichi Mori, Nobuaki Amino, Masahiro Takeuchi, Fumiko Tominaga, Isao Kinoyama, Akira Matsuhisa, Masafumi Kudou, Masao Sasamata, Broad spectrum and potent antitumor activities of YM155, a novel small-molecule survivin suppressant, in a wide variety of human cancer cell lines and xenograft models, Cancer Science, 2011, 102, 3
  15. 15
    Soo Hyeon Lee, Hyejung Mok, Sungduk Jo, Cheol Am Hong, Tae Gwan Park, Dual gene targeted multimeric siRNA for combinatorial gene silencing, Biomaterials, 2011, 32, 9, 2359

    CrossRef

  16. 16
    Kota Iwahori, Satoshi Serada, Minoru Fujimoto, Shintaro Nomura, Tadashi Osaki, Chun Man Lee, Hiroyuki Mizuguchi, Tsuyoshi Takahashi, Barry Ripley, Meinoshin Okumura, Ichiro Kawase, Tadamitsu Kishimoto, Tetsuji Naka, Overexpression of SOCS3 exhibits preclinical antitumor activity against malignant pleural mesothelioma, International Journal of Cancer, 2011, 129, 4
  17. 17
    Biao Yan, Research progress on Livin protein: an inhibitor of apoptosis, Molecular and Cellular Biochemistry, 2011, 357, 1-2, 39

    CrossRef

  18. 18
    S. Trabulo, A. M. Cardoso, T. Santos-Ferreira, A. L. Cardoso, S. Simões, M. C. Pedroso de Lima, Survivin Silencing as a Promising Strategy To Enhance the Sensitivity of Cancer Cells to Chemotherapeutic Agents, Molecular Pharmaceutics, 2011, 8, 4, 1120

    CrossRef

  19. 19
    Peixuan Guo, Oana Coban, Nicholas M. Snead, Joe Trebley, Steve Hoeprich, Songchuan Guo, Yi Shu, Engineering RNA for Targeted siRNA Delivery and Medical Application, Advanced Drug Delivery Reviews, 2010, 62, 6, 650

    CrossRef

  20. 20
    Y Shao, Y Liu, C Shao, J Hu, X Li, F Li, L Zhang, D Zhao, L Sun, X Zhao, D J Kopecko, D V Kalvakolanu, Y Li, D Q Xu, Enhanced tumor suppression in vitro and in vivo by co-expression of survivin-specific siRNA and wild-type p53 protein, Cancer Gene Therapy, 2010, 17, 12, 844

    CrossRef

  21. 21
    Xiao-Ming Bai, Hui Jiang, Jing-Xian Ding, Tao Peng, Juan Ma, Yao-Hui Wang, Li Zhang, Hai Zhang, Jing Leng, Prostaglandin E2 upregulates survivin expression via the EP1 receptor in hepatocellular carcinoma cells, Life Sciences, 2010, 86, 5-6, 214

    CrossRef

  22. You have open access to this content22
    Hideaki Karasawa, Koh Miura, Wataru Fujibuchi, Kazuyuki Ishida, Naoyuki Kaneko, Makoto Kinouchi, Mitsunori Okabe, Toshinori Ando, Yukio Murata, Hiroyuki Sasaki, Kazuhiro Takami, Akihiro Yamamura, Chikashi Shibata, Iwao Sasaki, Down-regulation of cIAP2 enhances 5-FU sensitivity through the apoptotic pathway in human colon cancer cells, Cancer Science, 2009, 100, 5
  23. 23
    Haiyan You, Jie Jin, Huiqun Shu, Bin Yu, Angelo De Milito, Francesco Lozupone, Yun Deng, Ning Tang, Genfu Yao, Stefano Fais, Jianren Gu, Wenxin Qin, Small interfering RNA targeting the subunit ATP6L of proton pump V-ATPase overcomes chemoresistance of breast cancer cells, Cancer Letters, 2009, 280, 1, 110

    CrossRef

  24. 24
    Bríd M. Ryan, Norma O’Donovan, Michael J. Duffy, Survivin: A new target for anti-cancer therapy, Cancer Treatment Reviews, 2009, 35, 7, 553

    CrossRef

  25. 25
    Kazunobu Futami, Emi Kumagai, Hiroshi Makino, Ayumi Sato, Motoki Takagi, Akira Shimamoto, Yasuhiro Furuichi, Anticancer activity of RecQL1 helicase siRNA in mouse xenograft models, Cancer Science, 2008, 99, 6
  26. You have open access to this content26
    Hirofumi Yamamoto, Chew Yee Ngan, Morito Monden, Cancer cells survive with survivin, Cancer Science, 2008, 99, 9
  27. 27
    Marzia Pennati, Marco Folini, Nadia Zaffaroni, Targeting survivin in cancer therapy, Expert Opinion on Therapeutic Targets, 2008, 12, 4, 463

    CrossRef

  28. 28
    Kristina Viktorsson, Rolf Lewensohn, Apoptotic Signaling Pathways in Lung Cancer, Journal of Thoracic Oncology, 2007, 2, 3, 175

    CrossRef

  29. 29
    Cheng-long Huang, Hiroyasu Yokomise, Akira Miyatake, Clinical significance of the p53 pathway and associated gene therapy in non-small cell lung cancers, Future Oncology, 2007, 3, 1, 83

    CrossRef

  30. 30
    Masato Ikeda, Isamu Okamoto, Kenji Tamura, Taroh Satoh, Kimio Yonesaka, Masahiro Fukuoka, Kazuhiko Nakagawa, Down-regulation of survivin by ultraviolet C radiation is dependent on p53 and results in G2–M arrest in A549 cells, Cancer Letters, 2007, 248, 2, 292

    CrossRef

  31. 31
    Li GONG, Xiaodong JIN, Qiang LI, Jiangtao LIU, Lizhe AN, Heavy Ion Beams Induce Survivin Expression in Human Hepatoma SMMC-7721 Cells More Effectively than X-rays, Acta Biochimica et Biophysica Sinica, 2007, 39, 8
  32. 32
    Bin Liu, Mei Han, Jin-Kun Wen, Ling Wang, Livin/ML-IAP as a new target for cancer treatment, Cancer Letters, 2007, 250, 2, 168

    CrossRef

  33. 33
    Shinya Abe, Maki Hasegawa, Kouhei Yamamoto, Morito Kurata, Yasunori Nakagawa, Kenshi Suzuki, Touichiro Takizawa, Masanobu Kitagawa, Rapid induction of IAP family proteins and Smac/DIABLO expression after proapoptotic stimulation with doxorubicin in RPMI 8226 multiple myeloma cells, Experimental and Molecular Pathology, 2007, 83, 3, 405

    CrossRef

  34. 34
    Ying Hu, Stefan Rahlfs, Volker Mersch-Sundermann, Katja Becker, Resveratrol modulates mRNA transcripts of genes related to redox metabolism and cell proliferation in non-small-cell lung carcinoma cells, Biological Chemistry, 2007, 388, 2

    CrossRef

  35. 35
    Yi-Guan Xu, Sheng-Hua Zhou, Yu-Guang Li, Chun-Hua Zheng, Xu-Ping Li, Qi-Ming Liu, Duan-Min Xu, Shang Chen, The Mechanism Underlying Vascular Smooth Muscle Cell Apoptosis Induced by Atorvastatin may be Mainly Associated with Down-regulation of Survivin Expression, Cardiovascular Drugs and Therapy, 2007, 21, 3, 145

    CrossRef

  36. 36
    Axel H. Schönthal, Antitumor properties of dimethyl-celecoxib, a derivative of celecoxib that does not inhibit cyclooxygenase-2: implications for glioma therapy, Neurosurgical FOCUS, 2006, 20, 4, E21

    CrossRef

  37. 37
    Yi Sun, E3 Ubiquitin Ligases as Cancer Targets and Biomarkers, Neoplasia, 2006, 8, 8, 645

    CrossRef

  38. 38
    Irena Crnković-Mertens, Thomas Muley, Michael Meister, Bettina Hartenstein, Julia Semzow, Karin Butz, Felix Hoppe-Seyler, The anti-apoptotic livin gene is an important determinant for the apoptotic resistance of non-small cell lung cancer cells, Lung Cancer, 2006, 54, 2, 135

    CrossRef

  39. 39
    Gustavo J. Gutierrez, Ze'ev Ronai, Ubiquitin and SUMO systems in the regulation of mitotic checkpoints, Trends in Biochemical Sciences, 2006, 31, 6, 324

    CrossRef